Renal hemodynamics in patients with diabetic nephropathy caused by arterial hypertension using magnetic laser therapy

Abstract

BACKGROUND: In recent decades, there has been a progressive increase in the number of patients with chronic kidney disease worldwide, which is associated with both an actual increase in the incidence of the disease, associated with cardiovascular pathology and type 2 diabetes mellitus, among other things, and an increase in the life expectancy of patients.

AIM: To assess hemodynamics of renal vessels during a course of magnetic laser therapy with the patients suffering from diabetic nephropathy caused by arterial hypertension against the background of the standard of care for this category of patients.

MATERIALS AND METHODS: There has been carried out a randomized controlled trial on 100 patients with diabetic nephropathy caused by arterial hypertension. Their average age was 61,7 [52,8; 69,7] years old, the duration of arterial hypertension ― 24,1 [14,5; 36,1], type 2 diabetes mellitus ― 16,6 [14,9; 19,1] and diabetic nephropathy ― 6,1 [4,2; 8,9] years. In addition to general clinical studies, the patients in the control group (49 people) before and after prescribing the standard medication, and in the main group (51 people) with additional use of magnetic laser therapy, had their renal blood flow examined by Doppler ultrasound.

RESULTS: The obtained data indicate the positive effect of magnetic laser therapy with the patients suffering from diabetic nephropathy caused by arterial hypertension on the hemodynamics of renal vessels with improved blood flow in arteries of both medium and small caliber, which, in turn, apparently should contribute to the normalization of the function of the capillary system of the renal parenchyma.

CONCLUSION: The results of the given study allow us to recommend the use of magnetic laser therapy in the complex rehabilitation treatment of the patients with diabetic nephropathy caused by arterial hypertension taking into account the criteria for their strict selection.

Keywords

magnetic laser therapy / diabetic nephropathy / arterial hypertension / renal hemodynamics

References

[1] Bommer J. Prevalence and socio-economic aspects of chronic kidney disease. Nephrol Dial Transplant. 2002;17(11):8–12. doi: 10.1093/ndt/17.suppl_11.8

[2] Bommer J. Prevalence and socio-economic aspects of chronic kidney disease // Nephrol Dial Transplant. 2002. Vol. 17, Suppl. 11. P. 8–12. doi: 10.1093/ndt/17.suppl_11.8

[3] Coresh J, Astor ВС, Greene Т, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(l):1–12. doi: 10.1053/ajkd.2003.50007

[4] Coresh J., Astor В.С., Greene Т., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey // Am J Kidney Dis. 2003. Vol. 41, N l. P. 1–12. doi: 10.1053/ajkd.2003.50007

[5] Jones CA. Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int. 2005;67(5):1684–1691. doi: 10.1111/j.1523-1755.2005.00265.x

[6] Jones C.A. Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? // Kidney Int. 2005. Vol. 67, N 5. P. 1684–1691. doi: 10.1111/j.1523-1755.2005.00265.x

[7] Moiseev VS, Mukhin NA, Smirnov AV, et al. Cardiovascular risk and chronic kidney disease: Cardio-nephroprotection strategies. Russ J Cardiol. 2014;19(8):7–37. EDN: SMGWFL

[8] Моисеев B.С., Мухин Н.А., Смирнов А.В., и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегия кардио-нефропротекции // Российский кардиологический журнал. 2014. Т. 19, № 8. С. 7–37. EDN: SMGWFL

[9] Bobkova IN, Vatazin AV, Vetchinnikova ON, et al. Chronic kidney disease (CKD). Clinical recommendations. 2021-2022-2023 (06/24/2021). Approved by the Ministry of Health of the Russian Federation. Moscow; 2021. 162 p. (In Russ).

[10] Бобкова И.Н., Ватазин А.В., Ветчинникова О.Н., и др. Хроническая болезнь почек (ХБП). Клинические рекомендации. 2021-2022-2023 (24.06.2021). Утверждены Минздравом РФ. Москва, 2021. 162 с.

[11] Dedov II, Shestakova MV, Mayorov AY, et al. Type 2 diabetes mellitus in adults. Clinical recommendations. 2019 (01/15/2020). Approved by the Ministry of Health of the Russian Federation. Moscow; 2018. 141 p. (In Russ).

[12] Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Сахарный диабет 2 типа у взрослых. Клинические рекомендации. 2019 (15.01.2020). Утверждены Минздравом РФ. Москва, 2018. 141 с.

[13] Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. clinical guidelines 2020. Russ J Cardiol. 2020;25(3):149–218. EDN: TCRBRB doi: 10.15829/1560-4071-2020-3-3786

[14] Кобалава Ж.Д., Конради А.О., Недогода С.В., и др. Артериальная гипертензия у взрослых. Клинические рекомендации. 2020 // Российский кардиологический журнал. 2020. Т. 25, № 3. С. 149–218. EDN: TCRBRB doi: 10.15829/1560-4071-2020-3-3786

[15] Badtieva VA. Physical factors in the treatment of patients with arterial hypertension with associated ischemic heart disease [dissertation abstract]: 14.00.51, 14.00.06. Place of protection: Russian Scientific Centre of Restorative Medicine and Balneology. Moscow; 2002. 44 p. (In Russ). EDN: VKQMCX

[16] Бадтиева В.А. Физические факторы в лечении больных артериальной гипертонией с ассоциированной ИБС: Автореф. дис. … д-ра мед. наук: 14.00.51, 14.00.06. Место защиты: Рос. науч. центр восстанов. мед. и курортологии. Москва, 2002. 44 с. EDN: VKQMCX

[17] Fedorov AA, Ryabko EV, Gromov AS. The use of magnetolaser therapy in the combined treatment of osteoarthrosis in workers exposed to the impact of inorganic fluoride compounds. Problems of balneology, physiotherapy and exercise therapy. 2010;(4):10–12. EDN: MWEUXN

[18] Федоров А.А., Рябко Е.В., Громов А.С. Магнитолазерная терапия в комплексном лечении остеоартроза у рабочих, подвергающихся воздействию неорганических соединений фтора // Вопросы курортологии, физиотерапии и лечебной физической культуры. 2010. № 4. С. 10–12. EDN: MWEUXN

[19] Spa treatment: national guidelines. Ed. by A.N. Razumov, V.I. Starodubov, G.N. Ponomarenko. Moscow: GEOTAR-Media; 2021. 752 p. (In Russ).

[20] Санаторно-курортное лечение: национальное руководство / под ред. А.Н. Разумова, В.И. Стародубова, Г.Н. Пономаренко. Москва: ГЕОТАР-Медиа, 2021. 752 c.

[21] Badtieva VA. Laser therapy for patients with hypertension and coronary insufficiency [dissertation abstract]: 14.00.34. Moscow; 1995. 24 p. (In Russ).

[22] Бадтиева В.А. Лазерная терапия больных гипертонической болезнью с коронарной недостаточностью: Автореф. дис. … канд. мед. наук: 14.00.34. Москва, 1995. 24 с.

[23] Physical and rehabilitation medicine: national guidelines. Ed. by G.N. Ponomarenko. 2nd revised and updated. Moscow: GEOTAR-Media, 2023. 912 p. (In Russ).

[24] Физическая и реабилитационная медицина: национальное руководство / под ред. Г.Н. Пономаренко. 2-е изд., перераб. и доп. Москва: ГЭОТАР-Медиа, 2023. 912 с.

RIGHTS & PERMISSIONS

Eco-Vector